Acetylcholine receptors: Key players in cancer development.
暂无分享,去创建一个
A. Kwong | V. Shin | Jiawei Chen | I. Cheuk
[1] Mi Zhang,et al. Muscarinic acetylcholine receptor M1 mediates prostate cancer cell migration and invasion through hedgehog signaling , 2018, Asian journal of andrology.
[2] Jinn-Moon Yang,et al. Nicotinic Acetylcholine Receptor Subtype Alpha-9 Mediates Triple-Negative Breast Cancers Based on a Spontaneous Pulmonary Metastasis Mouse Model , 2017, Front. Cell. Neurosci..
[3] Je-Yoel Cho,et al. The Role of Nitrosamine (NNK) in Breast Cancer Carcinogenesis , 2017, Journal of Mammary Gland Biology and Neoplasia.
[4] Qiu-lin Tang,et al. Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation , 2017, Scientific Reports.
[5] H. Tomita,et al. Nerve Growth Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling. , 2017, Cancer cell.
[6] Y. Lan,et al. The Functional Haplotypes of CHRM3 Modulate mRNA Expression and Associate with Bladder Cancer among a Chinese Han Population in Kaohsiung City , 2016, BioMed research international.
[7] Y. Ho,et al. Protein phosphatase Mg2+/Mn2+ dependent 1F promotes smoking-induced breast cancer by inactivating phosphorylated-p53-induced signals , 2016, Oncotarget.
[8] Ho Jin Lee,et al. Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation , 2016, Oncotarget.
[9] W. Hong,et al. The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cells , 2016, Nature Communications.
[10] J. Raufman,et al. Muscarinic receptor signaling and colon cancer progression , 2016, Journal of cancer metastasis and treatment.
[11] M. Sales. Muscarinic Receptors as Targets for Metronomic Therapy in Breast Cancer. , 2016, Current pharmaceutical design.
[12] Xianguang Meng,et al. Nicotinic acetylcholine receptors and cancer , 2016, Biomedical reports.
[13] R. Zhou,et al. MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells , 2016, Oncotarget.
[14] Li Yang,et al. Muscarinic receptor M3 mediates cell proliferation induced by acetylcholine and contributes to apoptosis in gastric cancer , 2016, Tumor Biology.
[15] M. Sales,et al. Participation of non-neuronal muscarinic receptors in the effect of carbachol with paclitaxel on human breast adenocarcinoma cells. Roles of nitric oxide synthase and arginase. , 2015, International immunopharmacology.
[16] L. Conti,et al. The activation of M2 muscarinic receptor inhibits cell growth and survival in human glioblastoma cancer stem cells. , 2015, International immunopharmacology.
[17] H. Bernard,et al. The nicotinic acetylcholine receptor-mediated reciprocal effects of the tobacco nitrosamine NNK and SLURP-1 on human mammary epithelial cells. , 2015, International immunopharmacology.
[18] C. Cao,et al. CHRNA5 rs16969968 Polymorphism Association with Risk of Lung Cancer--Evidence from 17,962 Lung Cancer Cases and 77,216 Control Subjects. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[19] J. Wess,et al. Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens , 2015, Proceedings of the National Academy of Sciences.
[20] Q. Lu,et al. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC) , 2015, Cancer biology & therapy.
[21] Bina Desai,et al. Selective targeting of M3 muscarinic receptors: an opportunity for improved treatment of upper gastrointestinal carcinomas , 2014 .
[22] V. Petrozza,et al. M2muscarinic receptors inhibit cell proliferation and migration in urothelial bladder cancer cells , 2014, Cancer biology & therapy.
[23] S. Grando,et al. Connections of nicotine to cancer , 2014, Nature Reviews Cancer.
[24] Saranya Chumsri,et al. Nicotine promotes apoptosis resistance of breast cancer cells and enrichment of side population cells with cancer stem cell-like properties via a signaling cascade involving galectin-3, α9 nicotinic acetylcholine receptor and STAT3 , 2014, Breast Cancer Research and Treatment.
[25] M. Adjobo-Hermans,et al. M3 Muscarinic Receptor Interaction with Phospholipase C β3 Determines Its Signaling Efficiency* , 2014, The Journal of Biological Chemistry.
[26] Longhua Sun,et al. Overexpression of Muscarinic Receptor 3 Promotes Metastasis and Predicts Poor Prognosis in Non–Small-Cell Lung Cancer , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[27] V. Pickel,et al. Somatodendritic targeting of M5 muscarinic receptor in the rat ventral tegmental area: Implications for mesolimbic dopamine transmission , 2013, The Journal of comparative neurology.
[28] S. Freedland,et al. Autonomic Nerve Development Contributes to Prostate Cancer Progression , 2013, Science.
[29] Wenjie Zhu,et al. Association of CHRNA5-A3-B4 Variation with Esophageal Squamous Cell Carcinoma Risk and Smoking Behaviors in a Chinese Population , 2013, PloS one.
[30] Man Jiang,et al. Is susceptibility locus for lung cancer in the 15q25 nicotinic acetylcholine receptor gene cluster CHRNA5-A3-B4 associated with risk of gastric cancer? , 2013, Medical Oncology.
[31] M. Sales,et al. Autoantibodies against Muscarinic Receptors in Breast Cancer: Their Role in Tumor Angiogenesis , 2013, PloS one.
[32] M. Sales,et al. Immunoglobulin G from Breast Cancer Patients Regulates MCF-7 Cells Migration and MMP-9 Activity by Stimulating Muscarinic Acetylcholine Receptors , 2013, Journal of Clinical Immunology.
[33] Nan Hua,et al. A Novel Muscarinic Antagonist R2HBJJ Inhibits Non-Small Cell Lung Cancer Cell Growth and Arrests the Cell Cycle in G0/G1 , 2012, PloS one.
[34] H. Anton-Culver,et al. Association of single nucleotide polymorphisms of nicotinic acetylcholine receptor subunits with cervical neoplasia. , 2012, Life sciences.
[35] Peng Wei,et al. Insights into Pancreatic Cancer Etiology from Pathway Analysis of Genome-Wide Association Study Data , 2012, PloS one.
[36] Hyun-Seok Kim,et al. Sensitization of epithelial growth factor receptors by nicotine exposure to promote breast cancer cell growth , 2011, Breast Cancer Research.
[37] P. Wei,et al. Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces α9-nicotinic acetylcholine receptor expression in human breast cancer cells , 2011, Breast Cancer Research and Treatment.
[38] N. Lambert,et al. Inactive-state preassembly of Gq-coupled receptors and Gq heterotrimers , 2011, Nature chemical biology.
[39] Y. Ho,et al. Nicotinic Acetylcholine Receptor-Based Blockade: Applications of Molecular Targets for Cancer Therapy , 2011, Clinical Cancer Research.
[40] J. Wess,et al. Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice , 2011, Psychopharmacology.
[41] L. Svensson,et al. Intestinal Epithelial Stem/Progenitor Cells Are Controlled by Mucosal Afferent Nerves , 2011, PloS one.
[42] Y. Sekino,et al. Nicotine increases cancer stem cell population in MCF-7 cells. , 2010, Biochemical and biophysical research communications.
[43] R. Linnoila. From nicotine to breast cancer, implications of cholinergic receptor pathway. , 2010, Journal of the National Cancer Institute.
[44] P. Wei,et al. Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells. , 2010, Journal of the National Cancer Institute.
[45] M. Sales,et al. Immunoglobulin G from Breast Cancer Patients in Stage I Stimulates Muscarinic Acetylcholine Receptors in MCF7 Cells and Induces Proliferation. Participation of Nitric Oxide Synthase-Derived Nitric Oxide , 2010, Journal of Clinical Immunology.
[46] J. Wess,et al. A Subpopulation of Neuronal M4 Muscarinic Acetylcholine Receptors Plays a Critical Role in Modulating Dopamine-Dependent Behaviors , 2010, The Journal of Neuroscience.
[47] M. Davare,et al. ERK activation and cell growth require CaM kinases in MCF-7 breast cancer cells , 2010, Molecular and Cellular Biochemistry.
[48] A. Khorram-Manesh,et al. Is acetylcholine an autocrine/paracrine growth factor via the nicotinic alpha7-receptor subtype in the human colon cancer cell line HT-29? , 2009, European journal of pharmacology.
[49] J. Raufman,et al. Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells. , 2009, American journal of physiology. Gastrointestinal and liver physiology.
[50] H. Schuller. Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? , 2009, Nature Reviews Cancer.
[51] J. Raufman,et al. Muscarinic receptors and ligands in cancer. , 2009, American journal of physiology. Cell physiology.
[52] B. Dean,et al. Muscarinic receptors: do they have a role in the pathology and treatment of schizophrenia? , 2008, Journal of neurochemistry.
[53] C. Drachenberg,et al. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[54] C. Busch,et al. Distribution of muscarinic receptor subtype M3 in melanomas and their metastases , 2008, Journal of cutaneous pathology.
[55] A. Cesario,et al. The cholinergic system and cancer. , 2008, Seminars in cancer biology.
[56] J. Wess,et al. Muscarinic receptor subtypes involved in carbachol-induced contraction of mouse uterine smooth muscle , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.
[57] G. Mills,et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.
[58] Daniel F. Gudbjartsson,et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease , 2008, Nature.
[59] Paolo Vineis,et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25 , 2008, Nature.
[60] P. Dasgupta,et al. Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis. , 2008, Trends in pharmacological sciences.
[61] Christopher J Langmead,et al. Muscarinic acetylcholine receptors as CNS drug targets. , 2008, Pharmacology & therapeutics.
[62] Richard M. Eglen,et al. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development , 2007, Nature Reviews Drug Discovery.
[63] Shan Li,et al. Effects of tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) on the activation of ERK1/2 MAP kinases and the proliferation of human mammary epithelial cells. , 2006, Environmental toxicology and pharmacology.
[64] W. Wu,et al. Functional Role of β-Adrenergic Receptors in the Mitogenic Action of Nicotine on Gastric Cancer Cells , 2006 .
[65] M. Matsui,et al. Differential Coupling of Muscarinic M1, M2, and M3 Receptors to Phosphoinositide Hydrolysis in Urinary Bladder and Longitudinal Muscle of the Ileum of the Mouse , 2006, Journal of Pharmacology and Experimental Therapeutics.
[66] Gary Kay,et al. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder , 2006, British journal of pharmacology.
[67] S. Rogers,et al. Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells , 2005, The AAPS Journal.
[68] W. Wu,et al. Nicotine Induces Cyclooxygenase-2 and Vascular Endothelial Growth Factor Receptor-2 in Association with Tumor-Associated Invasion and Angiogenesis in Gastric Cancer , 2005, Molecular Cancer Research.
[69] A. Boss,et al. Muscarinic cholinergic receptors in the human melanoma cell line SK‐Mel 28: modulation of chemotaxis , 2005, Clinical and experimental dermatology.
[70] E. Jiménez,et al. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells , 2005, Journal of cellular physiology.
[71] S. Yamada,et al. Quantitative analysis of binding parameters of [3H]N-methylscopolamine in central nervous system of muscarinic acetylcholine receptor knockout mice. , 2005, Brain research. Molecular brain research.
[72] J. Wess,et al. Vasodilatory effects of cholinergic agonists are greatly diminished in aorta from M3R-/- mice. , 2004, European journal of pharmacology.
[73] Hui-zhen Wang,et al. Functional M3 muscarinic acetylcholine receptors in mammalian hearts , 2004, British journal of pharmacology.
[74] Fengqin Gao,et al. Nicotine Induces Multi-site Phosphorylation of Bad in Association with Suppression of Apoptosis* , 2004, Journal of Biological Chemistry.
[75] J. Wess,et al. Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. , 2004, Annual review of pharmacology and toxicology.
[76] J. Raufman,et al. Transactivation of the epidermal growth factor receptor mediates cholinergic agonist-induced proliferation of H508 human colon cancer cells. , 2003, Cancer research.
[77] U. Drews,et al. Muscarinic receptors in cell lines from ovarian carcinoma: negative correlation with survival of patients. , 2002, Gynecologic oncology.
[78] A. Karlin. Ion channel structure: Emerging structure of the Nicotinic Acetylcholine receptors , 2002, Nature Reviews Neuroscience.
[79] J. Wess,et al. Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[80] G. Ayala,et al. In vitro dorsal root ganglia and human prostate cell line interaction: Redefining perineural invasion in prostate cancer , 2001, The Prostate.
[81] L. Potter,et al. Biotinylated m4-toxin demonstrates more M4 muscarinic receptor protein on direct than indirect striatal projection neurons , 2001, Brain Research.
[82] M. Bolognesi,et al. Prejunctional muscarinic inhibitory control of acetylcholine release in the human isolated detrusor: involvement of the M4 receptor subtype , 2000, British journal of pharmacology.
[83] M. Michel,et al. Adrenergic and muscarinic receptors in the human heart. , 1999, Pharmacological reviews.
[84] C. Kirkpatrick,et al. THE CHOLINERGIC ‘PITFALL’: ACETYLCHOLINE, A UNIVERSAL CELL MOLECULE IN BIOLOGICAL SYSTEMS, INCLUDING HUMANS , 1999, Clinical and experimental pharmacology & physiology.
[85] J. Wess,et al. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[86] R. Eglen,et al. Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder. , 1999, Life sciences.
[87] A. Fryer,et al. Muscarinic receptors and control of airway smooth muscle. , 1998, American journal of respiratory and critical care medicine.
[88] R. Carroll,et al. The m3 muscarinic acetylcholine receptor differentially regulates calcium influx and release through modulation of monovalent cation channels , 1998, The EMBO journal.
[89] N. Birdsall,et al. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. , 1998, Pharmacological reviews.
[90] A. Levey,et al. Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons , 1997, Synapse.
[91] M. Tonini,et al. M4 muscarinic autoreceptor-mediated inhibition of -3H-acetylcholine release in the rat isolated urinary bladder. , 1997, The Journal of pharmacology and experimental therapeutics.
[92] A. Höglund,et al. M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord. , 1997, The Journal of pharmacology and experimental therapeutics.
[93] A. Blum,et al. Immunohistochemical localization of muscarinic acetylcholine receptors in primary and metastatic malignant melanomas , 1997, Journal of cutaneous pathology.
[94] J. Phillips,et al. Variation in mRNA expression of alpha-adrenergic, neurokinin and muscarinic receptors amongst four arteries of the rat. , 1997, Journal of the autonomic nervous system.
[95] R. Hurst,et al. trp, a Novel Mammalian Gene Family Essential for Agonist-Activated Capacitative Ca2+ Entry , 1996, Cell.
[96] D. Jenden,et al. Cholinergic control of cerebral blood flow in stroke, trauma and aging. , 1996, Life sciences.
[97] N. Normanno,et al. Epidermal growth factor-related peptides and their receptors in human malignancies. , 1995, Critical reviews in oncology/hematology.
[98] M. Ruggieri,et al. Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. , 1995, The Journal of pharmacology and experimental therapeutics.
[99] A. Sato,et al. Cholinergic Neural Regulation of Regional Cerebral Blood Flow , 1995, Alzheimer disease and associated disorders.
[100] C. Felder. Muscarinic acetylcholine receptors: signal transduction through multiple effectors , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[101] A. Levey,et al. Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[102] A. Levey,et al. Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype- specific antibodies , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[103] R. Quirion,et al. Cholinergic markers in Alzheimer disease and the autoregulation of acetylcholine release. , 1993, Journal of psychiatry & neuroscience : JPN.
[104] R. Yasuda,et al. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain. , 1993, Molecular pharmacology.
[105] J. Pavia,et al. Muscarinic receptor subtypes in human and rat colon smooth muscle. , 1992, Biochemical pharmacology.
[106] S. Gauthier,et al. Comparative Alterations of Nicotinic and Muscarinic Binding Sites in Alzheimer's and Parkinson's Diseases , 1992, Journal of neurochemistry.
[107] A. Levey,et al. Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[108] M. Korc,et al. Identification and Characterization of Muscarinic Receptors in Cultured Human Pancreatic Carcinoma Cells , 1989, Pancreas.
[109] F. Abbas,et al. Differential receptor dependencies: expression and significance of muscarinic M1 receptors in the biology of prostate cancer , 2017, Anti-cancer drugs.
[110] P. Wei,et al. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins , 2010, Breast Cancer Research and Treatment.
[111] E. Albuquerque,et al. Mammalian nicotinic acetylcholine receptors: from structure to function. , 2009, Physiological reviews.
[112] M. Sopori,et al. Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility. , 2007, American journal of respiratory cell and molecular biology.
[113] R. Eglen. Muscarinic receptor subtype pharmacology and physiology. , 2005, Progress in medicinal chemistry.
[114] J. Wess,et al. Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice , 2003, Molecular Psychiatry.
[115] J. Blusztajn,et al. Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma. , 2003, Cancer research.
[116] E. Karaöz,et al. Expression of epidermal growth factor receptor in normal colonic mucosa and in adenocarcinomas of the colon. , 1997, Acta physiologica Hungarica.
[117] M. Caulfield. Muscarinic receptors--characterization, coupling and function. , 1993, Pharmacology & therapeutics.
[118] A. Levey,et al. Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. , 1993, Life sciences.
[119] N. Birdsall,et al. Muscarinic receptor subtypes. , 1990, Annual review of pharmacology and toxicology.